BLUEUnknown
bluebird bio, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for bluebird bio, Inc. (BLUE), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are BLUE insiders buying or selling?
bluebird bio, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since January 2018, Trabud has recorded 236 Form 4 filings for BLUE: 0 buys ($0) and 236 sells ($65.9M).
Source: SEC EDGAR Form 4
Key Statistics (January 2018 – Mar 5, 2025)
Total Form 4 filings
236
SEC EDGAR
Insider filers
21
Insider buys (0)
$0
Insider sells (236)
$65.9M
Insider sentiment
Net sellingNet insider flow of $65.9M in net selling since January 2018.
Recent BLUE insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | Richard A Colvin | Chief Medical Officer | Sale | 584 | $3.92 | $2.3K | SEC ↗ |
| Mar 5, 2025 | Thomas J Klima | Chief Commercial & Operating Officer | Sale | 500 | $3.92 | $2.0K | SEC ↗ |
| Mar 5, 2025 | Andrew Obenshain | President and CEO | Sale | 921 | $3.92 | $3.6K | SEC ↗ |
| Feb 5, 2025 | Thomas J Klima | Chief Commercial & Operating Officer | Sale | 122 | $7.39 | $901.89 | SEC ↗ |
| Feb 5, 2025 | Richard A Colvin | Chief Medical Officer | Sale | 64 | $7.39 | $473.12 | SEC ↗ |
| Feb 5, 2025 | Joseph Vittiglio | Chief Business & Legal Officer | Sale | 238 | $7.39 | $1.8K | SEC ↗ |
| Feb 5, 2025 | Andrew Obenshain | President and CEO | Sale | 86 | $7.39 | $635.76 | SEC ↗ |
| Jan 8, 2025 | Richard A Colvin | Chief Medical Officer | Sale | 19 | $9.24 | $175.56 | SEC ↗ |
| Jan 8, 2025 | Andrew Obenshain | President and CEO | Sale | 140 | $9.24 | $1.3K | SEC ↗ |
| Dec 12, 2024 | Andrew Obenshain | President and CEO | Sale | 971 | $0.42 | $405.2 | SEC ↗ |
| Dec 12, 2024 | Richard A Colvin | Chief Medical Officer | Sale | 2.8K | $0.42 | $1.2K | SEC ↗ |
| Oct 2, 2024 | Thomas J Klima | Chief Commercial & Operating Officer | Sale | 1.0K | $0.53 | $528.85 | SEC ↗ |
| Oct 2, 2024 | Andrew Obenshain | President and CEO | Sale | 34.8K | $0.53 | $18.3K | SEC ↗ |
| Jun 4, 2024 | Thomas J Klima | Chief Commercial & Operating Officer | Sale | 3.8K | $0.97 | $3.7K | SEC ↗ |
| Mar 5, 2024 | Richard A Colvin | Chief Medical Officer | Sale | 6.8K | $1.53 | $10.3K | SEC ↗ |
| Mar 5, 2024 | Andrew Obenshain | President and CEO | Sale | 6.1K | $1.53 | $9.3K | SEC ↗ |
| Mar 5, 2024 | Thomas J Klima | Chief Commercial & Operating Officer | Sale | 4.6K | $1.53 | $7.0K | SEC ↗ |
| Feb 6, 2024 | Thomas J Klima | Chief Commercial & Operating Officer | Sale | 2.7K | $0.90 | $2.4K | SEC ↗ |
| Feb 6, 2024 | Joseph Vittiglio | Chief Business & Legal Officer | Sale | 5.2K | $0.90 | $4.7K | SEC ↗ |
| Feb 6, 2024 | Andrew Obenshain | President and CEO | Sale | 1.9K | $0.90 | $1.7K | SEC ↗ |
| Jan 9, 2024 | Andrew Obenshain | President and CEO | Sale | 3.2K | $1.43 | $4.5K | SEC ↗ |
| Jan 9, 2024 | Richard A Colvin | Chief Medical Officer | Sale | 597 | $1.42 | $844.76 | SEC ↗ |
| Dec 8, 2023 | Christopher Krawtschuk | Chief Financial Officer | Sale | 4.5K | $4.52 | $20.4K | SEC ↗ |
| Nov 3, 2023 | Andrew Obenshain | President and CEO | Sale | 807 | $3.17 | $2.6K | SEC ↗ |
| Nov 3, 2023 | Richard A Colvin | Chief Medical Officer | Sale | 2.3K | $2.98 | $7.0K | SEC ↗ |
Showing the 25 most recent of 236 Form 4 filings for bluebird bio, Inc..
Most active BLUE insiders
- Philip D Gregory43 filings
- David Davidson40 filings
- Jason Cole22 filings
- Andrew Obenshain21 filings
- Nick Leschly17 filings
Ask anything about BLUE insider activity
Use Trabud's AI agent to query bluebird bio, Inc.'s Form 4 history in plain English — "Show me BLUE CEO purchases this year" or compare it against any other ticker.
Open the AI agentBLUE insider trading FAQ
Are bluebird bio, Inc. insiders buying or selling?
bluebird bio, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since January 2018, Trabud has recorded 236 Form 4 filings for BLUE: 0 buys ($0) and 236 sells ($65.9M). Over the full record that is net selling of $65.9M.
How many insiders trade BLUE stock?
21 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for bluebird bio, Inc.. The most recent filing was accepted on Mar 5, 2025.
Where does Trabud get BLUE insider trading data?
All BLUE insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.